Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

Richard N. Greenberg; Maria Yadira Hurley; Dinh V. Dinh; Serena Mraz; Javier Gomez Vera; Dorothea Von Bredow; Alfred Von Krempelhuber; Siegfried Roesch; Garth Virgin; Nathaly Arndtz-Wiedemann; Thomas Peter Meyer; Darja Schmidt; Richard Nichols; Philip Young; Paul Chaplin

doi:10.1371/journal.pone.0142802

Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

Richard N. Greenberg, Maria Yadira Hurley, Dinh V. Dinh, Serena Mraz, Javier Gomez Vera, Dorothea Von Bredow, Alfred Von Krempelhuber, Siegfried Roesch, Garth Virgin, Nathaly Arndtz-Wiedemann, Thomas Peter Meyer, Darja Schmidt, Richard Nichols, Philip Young, Paul Chaplin

Internal Medicine

Research output: Contribution to journal › Comment/debate

4 Scopus citations

Original language	English
Article number	e0142802
Journal	PLoS ONE
Volume	10
Issue number	11
DOIs	https://doi.org/10.1371/journal.pone.0142802
State	Published - Nov 10 2015

ASJC Scopus subject areas

General

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1371/journal.pone.0142802

Fingerprint

Dive into the research topics of 'Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))'. Together they form a unique fingerprint.

Cite this

Greenberg, R. N., Hurley, M. Y., Dinh, D. V., Mraz, S., Vera, J. G., Von Bredow, D., Von Krempelhuber, A., Roesch, S., Virgin, G., Arndtz-Wiedemann, N., Meyer, T. P., Schmidt, D., Nichols, R., Young, P., & Chaplin, P. (2015). Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802)). PLoS ONE, 10(11), Article e0142802. https://doi.org/10.1371/journal.pone.0142802

@article{0cda84bd76de411f96e2ffaa3a3c20f2,

title = "Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))",

author = "Greenberg, {Richard N.} and Hurley, {Maria Yadira} and Dinh, {Dinh V.} and Serena Mraz and Vera, {Javier Gomez} and {Von Bredow}, Dorothea and {Von Krempelhuber}, Alfred and Siegfried Roesch and Garth Virgin and Nathaly Arndtz-Wiedemann and Meyer, {Thomas Peter} and Darja Schmidt and Richard Nichols and Philip Young and Paul Chaplin",

year = "2015",

month = nov,

day = "10",

doi = "10.1371/journal.pone.0142802",

language = "English",

volume = "10",

number = "11",

}

Greenberg, RN, Hurley, MY, Dinh, DV, Mraz, S, Vera, JG, Von Bredow, D, Von Krempelhuber, A, Roesch, S, Virgin, G, Arndtz-Wiedemann, N, Meyer, TP, Schmidt, D, Nichols, R, Young, P & Chaplin, P 2015, 'Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))', PLoS ONE, vol. 10, no. 11, e0142802. https://doi.org/10.1371/journal.pone.0142802

Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802)). / Greenberg, Richard N.; Hurley, Maria Yadira; Dinh, Dinh V. et al.
In: PLoS ONE, Vol. 10, No. 11, e0142802, 10.11.2015.

Research output: Contribution to journal › Comment/debate

TY - JOUR

T1 - Erratum

T2 - A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

AU - Greenberg, Richard N.

AU - Hurley, Maria Yadira

AU - Dinh, Dinh V.

AU - Mraz, Serena

AU - Vera, Javier Gomez

AU - Von Bredow, Dorothea

AU - Von Krempelhuber, Alfred

AU - Roesch, Siegfried

AU - Virgin, Garth

AU - Arndtz-Wiedemann, Nathaly

AU - Meyer, Thomas Peter

AU - Schmidt, Darja

AU - Nichols, Richard

AU - Young, Philip

AU - Chaplin, Paul

PY - 2015/11/10

Y1 - 2015/11/10

UR - http://www.scopus.com/inward/record.url?scp=84953213735&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84953213735&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0142802

DO - 10.1371/journal.pone.0142802

M3 - Comment/debate

AN - SCOPUS:84953213735

SN - 1932-6203

VL - 10

JO - PLoS ONE

JF - PLoS ONE

IS - 11

M1 - e0142802

ER -

Greenberg RN, Hurley MY, Dinh DV, Mraz S, Vera JG, Von Bredow D et al. Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802)). PLoS ONE. 2015 Nov 10;10(11):e0142802. doi: 10.1371/journal.pone.0142802

Erratum: A multicenter, open-label, controlled phase II study to evaluate safety and immunogenicity of MVA smallpox vaccine (IMVAMUNE) in 18-40 year old subjects with diagnosed atopic dermatitis (PLoS ONE (2015) 10:11 (e0142802))

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this